OptimizeRx Financials - Benzinga

OptimizeRx Corp

OPRXNASDAQ

Trade with Public

Trade with Public

$8.72

-0.06-0.68%

At close: Aug 14, 5:00 PM EST

$8.60

-0.12-1.38%

After Hours: 7:59 PM EST

Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close

Conference Call: The most recent conference call started at 4:30 PM, 3 days ago

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

OptimizeRx Financials

OptimizeRx (OPRX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
OptimizeRx Affirms FY2026 Sales Guidance of $95.000M-$100.000M vs $97.427M Est

OptimizeRx (NASDAQ:OPRX) affirms FY2026 sales outlook from $95.000 million-$100.000 million to $95.000 million-$100.000 million vs $97.427 million estimate.

Benzinga Newsdesk

PRO
OptimizeRx Q2 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $20.504M Beat $20.204M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.12 by 33.33 percent. This is a 33.33 percent decrease over earnings of $0.24 per share from the

Benzinga Newsdesk

PRO
OptimizeRx Lowers FY2026 Sales Guidance from $109.000M-$114.000M to $95.000M-$100.000M vs $111.438M Est

OptimizeRx (NASDAQ:OPRX) lowers FY2026 sales outlook from $109.000 million-$114.000 million to $95.000 million-$100.000 million vs $111.438 million estimate.

Benzinga Newsdesk

PRO
OptimizeRx Q1 Adj. EPS $0.14 Beats $0.00 Estimate, Sales $19.844M Beat $18.353M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 75 percent increase over earnings of $0.08 per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 12, 2026

Benzinga Insights

OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty

OptimizeRx CEO warns of increased market volatility and uncertainty around MFN pricing. Lower 2026 forecasts due to cautious spending.

Vandana Singh